CYTOPOINT™ gives damaged skin a chance to heal after 1 injection1
*Treatment success was defined as a ≥50% reduction from baseline in skin condition scores as assessed by veterinarians using the Canine Atopic Dermatitis Extent and Severity Index (CADESI-03) score. CADESI-03 skin condition assessment consisted of an evaluation of erythema, lichenification, excoriation and self-induced alopecia at 62 body sites.1
†Significantly different compared to placebo (P≤0.05).
Indication: CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.
Reference: 1. Data on file, Study Report No. C863R-US-12-018, Zoetis LLC.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
Zoetis Services LLC. All rights reserved. CYT-00090